Azam Bolhassani

Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2018-2024
Publications (10 Years): 42

Top Topics

Men Who Have Sex With Men

Immune Response

Top Venues

Biotechnology letters

Therapeutic delivery

Molecular biotechnology

This page only lists publications with an associated author ORCID identifier.

Publications

Fatemeh Heidarnejad, Ali Namvar, Seyed Mehdi Sadat, Parisa Moradi Pordanjani, Fatemeh Rezaei, Haideh Namdari, Sina Arjmand, Azam Bolhassani
In silico designing of novel epitope-based peptide vaccines against HIV-1. Biotechnology letters (2024)
Fatemeh Heidarnejad, Ali Namvar, Seyed Mehdi Sadat, Parisa Moradi Pordanjani, Fatemeh Rezaei, Haideh Namdari, Sina Arjmand, Azam Bolhassani
In silico designing of novel epitope-based peptide vaccines against HIV-1. Biotechnology letters 46 (3) (2024)
Fatemeh Heidarnejad, Ali Namvar, Seyed Mehdi Sadat, Parisa Moradi Pordanjani, Fatemeh Rezaei, Haideh Namdari, Sina Arjmand, Azam Bolhassani
In silico designing of novel epitope-based peptide vaccines against HIV-1. Biotechnology letters 46 (3) (2024)
Fatemeh Heidarnejad, Ali Namvar, Seyed Mehdi Sadat, Parisa Moradi Pordanjani, Fatemeh Rezaei, Haideh Namdari, Sina Arjmand, Azam Bolhassani
In silico designing of novel epitope-based peptide vaccines against HIV-1. Biotechnology letters 46 (3) (2024)
Niloofar Khairkhah, Azam Bolhassani, Farzad Rajaei, Reza Najafipour
Systemic delivery of specific and efficient CRISPR/Cas9 system targeting HPV16 oncogenes using LL-37 antimicrobial peptide in C57BL/6 mice. Journal of medical virology 95 (7) (2023)
Niloofar Khairkhah, Ali Namvar, Azam Bolhassani
Application of Cell Penetrating Peptides as a Promising Drug Carrier to Combat Viral Infections. Molecular biotechnology (2023)
Alireza Milani, Elahe Akbari, Parisa Moradi Pordanjani, Fateme Jamshidi, Shahrzad Ghayoumi, Seyed Amir Sadeghi, Azam Bolhassani
Immunostimulatory effects of Hsp70 fragments and Hsp27 in design of novel HIV-1 vaccine formulations. HIV medicine (2023)
Farkhondeh Pooresmaeil, Sahar Andi, Behnam Hasannejad-Asl, Shahla Takamoli, Azam Bolhassani
Engineered exosomes: a promising vehicle in cancer therapy. Therapeutic delivery 14 (12) (2023)
Farkhondeh Pooresmaeil, Sahar Andi, Behnam Hasannejad-Asl, Shahla Takamoli, Azam Bolhassani
Engineered exosomes: a promising vehicle in cancer therapy. Therapeutic delivery 14 (12) (2023)
Farkhondeh Pooresmaeil, Sahar Andi, Behnam Hasannejad-Asl, Shahla Takamoli, Azam Bolhassani
Engineered exosomes: a promising vehicle in cancer therapy. Therapeutic delivery (2023)
Niloofar Khairkhah, Ali Namvar, Azam Bolhassani
Application of Cell Penetrating Peptides as a Promising Drug Carrier to Combat Viral Infections. Molecular biotechnology (2023)
Farkhondeh Pooresmaeil, Sahar Andi, Behnam Hasannejad-Asl, Shahla Takamoli, Azam Bolhassani
Engineered exosomes: a promising vehicle in cancer therapy. Therapeutic delivery 14 (12) (2023)
Elahe Akbari, Alireza Milani, Masoud Seyedinkhorasani, Azam Bolhassani
HPV co-infections with other pathogens in cancer development: A comprehensive review. Journal of medical virology 95 (11) (2023)
Fatemeh Heidarnejad, Azam Bolhassani, Soheila Ajdary, Alireza Milani, Seyed Amir Sadeghi
Investigation of Immunostimulatory Effects of IFN-γ Cytokine and CD40 Ligand Costimulatory Molecule for Development of HIV-1 Therapeutic Vaccine Candidate. Advanced biology (2023)
Niloofar Khairkhah, Azam Bolhassani, Reza Najafipour
Current and future direction in treatment of HPV-related cervical disease. Journal of molecular medicine (Berlin, Germany) 100 (6) (2022)
Azam Bolhassani
Lipid-Based Delivery Systems in Development of Genetic and Subunit Vaccines. Molecular biotechnology (2022)
Arash Nikyar, Azam Bolhassani, Elnaz Agi
LL-37 antimicrobial peptide and heterologous prime-boost vaccination regimen significantly induce HIV-1 Nef-Vpr antigen- and virion-specific immune responses in mice. Biotechnology letters 45 (1) (2022)
Seyed Amir Sadeghi Najafabadi, Azam Bolhassani, Mohammad Reza Aghasadeghi
Tumor cell-based vaccine: an effective strategy for eradication of cancer cells. Immunotherapy 14 (8) (2022)
Niloofar Khairkhah, Azam Bolhassani, Elnaz Agi, Ali Namvar, Arash Nikyar
Immunological investigation of a multiepitope peptide vaccine candidate based on main proteins of SARS-CoV-2 pathogen. PloS one 17 (6) (2022)
Arash Nikyar, Azam Bolhassani, Elnaz Agi
LL-37 antimicrobial peptide and heterologous prime-boost vaccination regimen significantly induce HIV-1 Nef-Vpr antigen- and virion-specific immune responses in mice. Biotechnology letters 45 (1) (2022)
Arash Nikyar, Azam Bolhassani, Elnaz Agi
LL-37 antimicrobial peptide and heterologous prime-boost vaccination regimen significantly induce HIV-1 Nef-Vpr antigen- and virion-specific immune responses in mice. Biotechnology letters 45 (1) (2022)
Arash Nikyar, Azam Bolhassani, Elnaz Agi
LL-37 antimicrobial peptide and heterologous prime-boost vaccination regimen significantly induce HIV-1 Nef-Vpr antigen- and virion-specific immune responses in mice. Biotechnology letters 45 (1) (2022)
Arash Nikyar, Azam Bolhassani, Elnaz Agi
LL-37 antimicrobial peptide and heterologous prime-boost vaccination regimen significantly induce HIV-1 Nef-Vpr antigen- and virion-specific immune responses in mice. Biotechnology letters (2022)
Saba Davoodi, Azam Bolhassani, Fatemeh Namazi
In vivo delivery of a multiepitope peptide and Nef protein using novel cell-penetrating peptides for development of HIV-1 vaccine candidate. Biotechnology letters 43 (3) (2021)
Kimia Kardani, Azam Bolhassani
Exploring novel and potent cell penetrating peptides in the proteome of SARS-COV-2 using bioinformatics approaches. PloS one 16 (2) (2021)
Ali Namvar, Azam Bolhassani, Gholamreza Javadi, Zahra Noormohammadi
Combination of human papillomaviruses L1 and L2 multiepitope constructs protects mice against tumor cells. Fundamental & clinical pharmacology 35 (6) (2021)
Kimia Kardani, Azam Bolhassani
Antimicrobial/anticancer peptides: bioactive molecules and therapeutic agents. Immunotherapy 13 (8) (2021)
Kimia Kardani, Seyed Mehdi Sadat, Mona Kardani, Azam Bolhassani
The next generation of HCV vaccines: a focus on novel adjuvant development. Expert review of vaccines 20 (7) (2021)
Alireza Milani, Azam Bolhassani, Fatemeh Rouhollah, Maryam Naseroleslami
Which one of the thermal approaches (heating DNA or cells) enhances the gene expression in mammalian cells? Biotechnology letters 43 (10) (2021)
Matin Kayyal, Azam Bolhassani, Zahra Noormohammadi, Majid Sadeghizadeh
In Silico Design and Immunological Studies of Two Novel Multiepitope DNA-Based Vaccine Candidates Against High-Risk Human Papillomaviruses. Molecular biotechnology 63 (12) (2021)
Elnaz Abbasifarid, Azam Bolhassani, Shiva Irani, Fattah Sotoodehnejadnematalahi
Synergistic effects of exosomal crocin or curcumin compounds and HPV L1-E7 polypeptide vaccine construct on tumor eradication in C57BL/6 mouse model. PloS one 16 (10) (2021)
Amin Hadi, Abbas Rastgoo, Maryam Eskandarian, Nooshin Haghighipour, Azam Bolhassani
Development of Delivery Systems Enhances the Potency of Cell-Based HIV-1 Therapeutic Vaccine Candidates. Journal of immunology research 2021 (2021)
Elahe Akbari, Kimia Kardani, Ali Namvar, Soheila Ajdary, Esmat Mirabzadeh Ardakani, Vahid Khalaj, Azam Bolhassani
In silico design and in vitro expression of novel multiepitope DNA constructs based on HIV-1 proteins and Hsp70 T-cell epitopes. Biotechnology letters 43 (8) (2021)
Amin Hadi, Abbas Rastgoo, Maryam Eskandarian, Nooshin Haghighipour, Azam Bolhassani
Erratum to "Development of Delivery Systems Enhances the Potency of Cell-Based HIV-1 Therapeutic Vaccine Candidates". Journal of immunology research 2021 (2021)
Kimia Kardani, Azam Bolhassani, Elnaz Agi, Atieh Hashemi
B1 protein: a novel cell penetrating protein for in vitro and in vivo delivery of HIV-1 multi-epitope DNA constructs. Biotechnology letters 42 (10) (2020)
Ali Namvar, Heidar Ali Panahi, Elnaz Agi, Azam Bolhassani
Development of HPV16,18,31,45 E5 and E7 peptides-based vaccines predicted by immunoinformatics tools. Biotechnology letters 42 (3) (2020)
Niloofar Khairkhah, Mohammad Reza Aghasadeghi, Ali Namvar, Azam Bolhassani
Design of novel multiepitope constructs-based peptide vaccine against the structural S, N and M proteins of human COVID-19 using immunoinformatics analysis. PloS one 15 (10) (2020)
Azam Bolhassani
Improvements in chemical carriers of proteins and peptides. Cell biology international 43 (4) (2019)
Kimia Kardani, Atieh Hashemi, Azam Bolhassani
Comparison of HIV-1 Vif and Vpu accessory proteins for delivery of polyepitope constructs harboring Nef, Gp160 and P24 using various cell penetrating peptides. PloS one 14 (10) (2019)
Bahareh Rostami, Shiva Irani, Azam Bolhassani, Reza Ahangari Cohan
Gene and protein delivery using four cell penetrating peptides for HIV-1 vaccine development. IUBMB life 71 (10) (2019)
Azam Bolhassani, Sepideh Shahbazi, Alireza Milani, Seyed Alireza Nadji
Small Heat Shock Proteins B1 and B6: Which One is the Most Effective Adjuvant in Therapeutic HPV Vaccine? IUBMB life 70 (10) (2018)
Niloofar Khairkhah, Ali Namvar, Kimia Kardani, Azam Bolhassani
Prediction of cross-clade HIV-1 T-cell epitopes using immunoinformatics analysis. Proteins 86 (12) (2018)